Rapafusyn Pharmaceuticals raised $28M in a Series A funding led by 3E Bioventures Capital and Proxima Ventures Ltd.
Amount Raised
$28 Million
Round Type
Series A
BaltimoreBiotechnologyTherapeuticsInvestors
Description
Rapafusyn Pharmaceuticals, a Baltimore, MD-based company specializing in the discovery and development of therapeutic drugs based on non-degrading molecular glues, raised $28M in Series A funding. The round was led by 3E Bioventures Capital and Proxima Ventures Ltd. with participation from Lapam Capital. The company intends to use the funds to accelerate the progress of its pipeline of macrocyclic peptide-based non-degrading molecular glues and further enhance its internal capabilities.
Quick answer
Rapafusyn Pharmaceuticals raised $28 Million in a Series A round, dated June 24, 2024. Investors: Lapam Capital, Proxima Ventures Ltd. and 3 E Bioventures Capital. Rapafusyn Pharmaceuticals is based in Baltimore, Maryland, United States.
- How much did Rapafusyn Pharmaceuticals raise?
- Rapafusyn Pharmaceuticals raised $28 Million in a Series A round on June 24, 2024.
- Who invested in Rapafusyn Pharmaceuticals?
- Lapam Capital, Proxima Ventures Ltd. and 3 E Bioventures Capital are named as investors in this round.
- What does Rapafusyn Pharmaceuticals do?
- Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland.
- Where is Rapafusyn Pharmaceuticals based and how big is it?
- Rapafusyn Pharmaceuticals is based in Baltimore, Maryland, United States. Fundz records about 17 employees.
- Who are the decision-makers at Rapafusyn Pharmaceuticals?
- Fundz holds 2 contacts at Rapafusyn Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Rapafusyn Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- IDRx raised $120M (Series B) on August 7, 2024.
- PolyPid raised $14M on August 6, 2024.
- NeuroTherapia raised $12M (Series B) on August 6, 2024.
- bioAffinity Technologies raised $450K on August 5, 2024.
- bioAffinity Technologies raised $1.3M on August 2, 2024.
- Lapix Therapeutics raised $2.2M on August 2, 2024.
Who to call at Rapafusyn Pharmaceuticals, and when
A new round usually means Rapafusyn Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rapafusyn Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rapafusyn Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rapafusyn Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rapafusyn Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRapafusyn Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.